These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37631385)

  • 1. QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency.
    Sun G; Bai P; Fan T; Zhao L; Zhong R; McElhinney RS; McMurry TBH; Donnelly DJ; McCormick JE; Kelly J; Margison GP
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631385
    [No Abstract]   [Full Text] [Related]  

  • 2. In Silico Prediction of O⁶-Methylguanine-DNA Methyltransferase Inhibitory Potency of Base Analogs with QSAR and Machine Learning Methods.
    Sun G; Fan T; Sun X; Hao Y; Cui X; Zhao L; Ren T; Zhou Y; Zhong R; Peng Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30404161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
    Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
    Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazene compounds: mechanism of action and related DNA repair systems.
    Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
    Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.
    Srivenugopal KS; Rawat A; Niture SK; Paranjpe A; Velu C; Venugopal SN; Madala HR; Basak D; Punganuru SR
    Mini Rev Med Chem; 2016; 16(6):455-64. PubMed ID: 26202203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating MGMT expression through interfering with cell signaling pathways.
    Bai P; Fan T; Wang X; Zhao L; Zhong R; Sun G
    Biochem Pharmacol; 2023 Sep; 215():115726. PubMed ID: 37524206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.
    Kaina B; Margison GP; Christmann M
    Cell Mol Life Sci; 2010 Nov; 67(21):3663-81. PubMed ID: 20717836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
    No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acridine-O
    Franco Pinto J; Fillion A; Duchambon P; Bombard S; Granzhan A
    Eur J Med Chem; 2022 Jan; 227():113909. PubMed ID: 34731767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
    Kaina B; Christmann M; Naumann S; Roos WP
    DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.
    Mühlhausen U; Schirrmacher R; Piel M; Lecher B; Briegert M; Piee-Staffa A; Kaina B; Rösch F
    J Med Chem; 2006 Jan; 49(1):263-72. PubMed ID: 16392811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals modulate expression of O⁶-methylguanine DNA methyltransferase (O⁶-MGMT) gene in the hermaphroditic fish, Kryptolebias marmoratus.
    Rhee JS; Kim RO; Chang HH; Lee J; Lee YM; Lee JS
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Jan; 153(1):141-9. PubMed ID: 20965277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction.
    Göder A; Nagel G; Kraus A; Dörsam B; Seiwert N; Kaina B; Fahrer J
    Carcinogenesis; 2015 Aug; 36(8):817-31. PubMed ID: 25998848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells.
    Senhaji Mouhri Z; Goodfellow E; Jean-Claude B
    BMC Cancer; 2017 Aug; 17(1):540. PubMed ID: 28800752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine.
    Woolford LB; Southgate TD; Margison GP; Milsom MD; Fairbairn LJ
    J Gene Med; 2006 Jan; 8(1):29-34. PubMed ID: 16075413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
    Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
    Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Key Structural Features of Various Butyrylcholinesterase Inhibitors Using Simple Molecular Descriptors.
    Miličević A; Šinko G
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
    Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
    Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.